RoundTable Healthcare Partners has completed the sale of the topical pharmaceutical business of its portfolio company Renaissance Acquisition Holdings to pharmaceutical company Mylan NV for $950 million in cash plus up to an additional $50 million in contingent payments. “Renaissance is another example of RoundTable partnering with owner/founders to accelerate revenue and earnings growth in…...
Pharmaceuticals
RoundTable Sells Topical Pharma Division
RoundTable Healthcare Partners has sold the topical pharmaceutical business of its portfolio company Renaissance Acquisition Holdings to pharmaceutical company Mylan NV for $950 million in cash at closing plus up to an additional $50 million in contingent payments. The topical division of Renaissance develops, manufactures, markets and sells branded and generic topical pharmaceutical products. RoundTable…...
TPG to Acquire Aptalis Pharmaceutical
TPG and Actavis have entered in an agreement for TPG to acquire Aptalis Pharmaceutical Technologies (APT), a pharmaceutical outsourcing and R&D business. APT is currently owned by Aptalis, an operating subsidiary of Actavis. The transaction is expected to close by mid-2015. APT is a pharmaceutical R&D and manufacturing company with specialized capabilities in taste-masking and…...
DFW Exits Vidara Therapeutics
DFW Capital Partners has completed the previously announced sale of its portfolio company, Vidara Therapeutics, to Horizon Pharma, in a cash and stock transaction valued at approximately $587 million. DFW invested in Vidara in 2012 through its third private equity fund, DFW Capital Partners III, LP. Vidara is a specialty pharmaceutical developer and marketer, focused…...
American Capital Exits Scientific Protein Laboratories
American Capital has sold its portfolio company SPL Acquisition, parent company to Scientific Protein Laboratories , to Shenzhen Hepalink Pharmaceutical Co. Scientific Protein Laboratories (SPL) is a manufacturer and supplier of active pharmaceutical ingredients with a focus on pancreatic enzymes and heparin. SPL specializes in cGMP (Current Good Manufacturing Practice) biopharmaceutical manufacturing and is one…...
